The impact of lipid-lowering treatment patterns on LDL-C reduction and goal attainment in secondary prevention in Germany

Current statinmonotherapy-dominated LLT in Germany failed to get the majority of patients to recommended LDL-C goal of <100 mg/dL. Improved lipid management strategies are required so that patients on LLT get the necessary reductions in LDL-C and the benefits of projected reductions in CVD morbidity and mortality.